|
GLP 1 (1-37) (human)
|
|
87805-34-3
|
|
Grubbs Catalyst M206
|
|
373640-75-6
|
|
Givinostat hydrochloride
|
|
199657-29-9
|
|
Gold(III) acetate
|
|
15804-32-7
|
|
GPBAR-A
|
|
877052-79-4
|
|
Gaboxadol
|
|
64603-91-4
|
|
Gedunin
|
|
2753-30-2
|
|
GSK429286A (DMSO solution)
|
|
864082-47-3
|
|
GSK-3 Inhibitor IX, Control, MeBIO
|
|
710323-61-8
|
|
GKA 50
|
|
851884-87-2
|
|
Gue 1654
|
|
397290-30-1
|
|
Go 6976 (DMSO solution)
|
|
136194-77-9
|
|
GLP-1 (7-37)
|
|
106612-94-6
|
|
Guanidinoethyl Sulfonate
|
|
543-18-0
|
|
GYKI 52466 dihydrochloride
|
|
2319722-40-0
|
|
Galiellalactone
|
|
133613-71-5
|
|
β-Gal NONOate
|
|
357192-78-0
|
|
GR 125743
|
|
148547-33-5
|
|
G5
|
|
108477-18-5
|
|
GYKI 53655 hydrochloride
|
|
143692-48-2
|
|
GSK-J5
|
|
1394854-51-3
|
|
GGTI-298 TFA
|
|
1217457-86-7
|
|
Geodin
|
|
427-63-4
|
|
Ibiglustat
|
|
1401090-53-6
|
|
Guanylin (rat, mouse)
|
|
144940-98-7
|
|
GW 583340 dihydrochloride
|
|
1173023-85-2
|
|
Gold(III) oxide
|
|
1303-58-8
|
|
Gemcitabine monophosphate
|
|
116371-67-6
|
|
GIP(1-39) TFA
|
|
725474-97-5
|
|
Gly MCA
|
|
66225-78-3
|
|
G 5555
|
|
1648863-90-4
|
|
Ganglioside GM3 sodium salt
|
|
54827-14-4
|
|
Glycylglycyl-l-isoleucine
|
|
69242-40-6
|
|
GNE 9278
|
|
901230-11-3
|
|
Grubbs Catalyst M207
|
|
253688-91-4
|
|
GpCp (GMPCP)
|
|
32381-15-0
|
|
Gilvocarcin V
|
|
77879-90-4
|
|
Gadolinium iodide
|
|
13572-98-0
|
|
3-Phenyl-1H-inden-1-ylidene[bis(i-butylphobane)]ruthenium(II) dichloride
|
|
894423-99-5
|
|
GW 590735
|
|
622402-22-6
|
|
Golgicide A
|
|
1005036-73-6
|
|
Glucoraphanin potassium salt
|
|
21414-41-5
|
|
GLP-2 (human) TFA salt
|
|
223460-79-5
|
|
Ganglioside GD1b disodium salt (bovine brain)
|
|
19553-76-5
|
|
GSA10
|
|
300833-95-8
|
|
GLP-2 (RAT)
|
|
195262-56-7
|
|
Gentianose
|
|
25954-44-3
|
|
GSK 9027
|
|
1229096-88-1
|
|
GPi 688
|
|
918902-32-6
|
|
GSK 2194069
|
|
1332331-08-4
|
|
Glyco-SNAP-1
|
|
188849-81-2
|
|
GS 143
|
|
916232-21-8
|
|
Grubbs Catalyst M104
|
|
1190427-44-1
|
|
GSK 1702934A
|
|
924377-85-5
|
|
Benzyl glycinate
|
|
1738-68-7
|
|
GW2580 (DMSO solution)
|
|
870483-87-7
|
|
GW 803430
|
|
515141-51-2
|
|
Glycochenodeoxycholic acid 3-sulfate disodium salt
|
|
66874-09-7
|
|
GSK-356278
|
|
720704-34-7
|
|
GYKI 47261 dihydrochloride
|
|
1217049-32-5
|
|
Guangxitoxin 1E trifluoroacetate salt
|
|
1233152-82-3
|
|
GR 144053 trihydrochloride
|
|
1215333-48-4
|
|
Gadolinium(III) acetylacetonate
|
|
14284-87-8
|
|
α-1,4-Galactosyltransferase
|
|
52725-57-2
|
|
GW791343
|
|
1019779-04-4
|
|
GSK 264220A
|
|
685506-42-7
|
|
Grifolic acid
|
|
80557-12-6
|
|
Garenoxacin mesylate monohydrate
|
|
223652-90-2
|
|
Guanosine 5′-triphosphate dilithium salt
|
|
85737-04-8
|
|
glycine, n-[2-[[(9h-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-n-(methylsulfonyl)-
|
|
1335206-40-0
|
|
GSK-239512
|
|
720691-69-0
|
|
[Gln8]-LH-RH (chicken)
|
|
47922-48-5
|
|
GSK 2250665A
|
|
1246030-96-5
|
|
GYKI 52466
|
|
102771-26-6
|
|
Geninthiocin
|
|
158792-27-9
|
|
Galloflavin
|
|
1780260-20-9
|
|
GSK 1562590 hydrochloride
|
|
1003878-07-6
|
|
GTPalphaS (aqueous solution)
|
|
81570-51-6
|
|
Glucose Pentasulfate, Potassium Salt
|
|
359435-44-2
|
|
GSK J5 HCl
|
|
1797983-32-4
|
|
Gilvocarcin M
|
|
77879-89-1
|
|
GM1 Pentasaccharide sodium salt
|
|
67063-78-9
|
|
GR113808
|
|
144625-51-4
|
|
GR 55562 dihydrochloride
|
|
159533-25-2
|
|
GEA 5024
|
|
144575-27-9
|
|
Grubbs Catalyst M310
|
|
1031262-76-6
|
|
GNTI dihydrochloride
|
|
351183-88-5
|
|
GEA 3162
|
|
144575-47-3
|
|
GoSlo SR 5-69
|
|
1363419-31-1
|
|
GGTI-286
|
|
171744-11-9
|
|
Gadolinium(III) hydroxide hydrate
|
|
100634-91-1
|
|
Glycyl-4-aminobutyric Acid
|
|
32595-49-6
|
|
Glycyl-H 1152 dihydrochloride
|
|
913844-45-8
|
|
Galbinic acid
|
|
56691-88-4
|
|
GW 1929 hydrochloride
|
|
1217466-21-1
|
|
Goralatide
|
|
120081-14-3
|
|
GSK-LSD1 Dihydrochloride
|
|
2102933-95-7
|
|
GR 203040
|
|
168398-02-5
|
|
GR 125487 sulfamate
|
|
859502-43-5
|
|
Gabapentin enacarbil
|
|
478296-72-9
|